- Home
- SNOA vs LRHC Comparison
SNOA vs LRHC Comparison
Compare SNOA & LRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNOA
- LRHC
- Stock Information
- Founded
- SNOA 1999
- LRHC 2004
- Country
- SNOA United States
- LRHC United States
- Employees
- SNOA N/A
- LRHC N/A
- Industry
- SNOA Biotechnology: Pharmaceutical Preparations
- LRHC
- Sector
- SNOA Health Care
- LRHC
- Exchange
- SNOA Nasdaq
- LRHC Nasdaq
- Market Cap
- SNOA 6.4M
- LRHC 5.6M
- IPO Year
- SNOA 2007
- LRHC 2023
- Fundamental
- Price
- SNOA $3.56
- LRHC $7.86
- Analyst Decision
- SNOA
- LRHC
- Analyst Count
- SNOA 0
- LRHC 0
- Target Price
- SNOA N/A
- LRHC N/A
- AVG Volume (30 Days)
- SNOA 83.7K
- LRHC 534.1K
- Earning Date
- SNOA 08-07-2025
- LRHC 08-14-2025
- Dividend Yield
- SNOA N/A
- LRHC N/A
- EPS Growth
- SNOA N/A
- LRHC N/A
- EPS
- SNOA N/A
- LRHC N/A
- Revenue
- SNOA $14,288,000.00
- LRHC $73,874,281.00
- Revenue This Year
- SNOA $23.00
- LRHC N/A
- Revenue Next Year
- SNOA $24.59
- LRHC N/A
- P/E Ratio
- SNOA N/A
- LRHC N/A
- Revenue Growth
- SNOA 12.20
- LRHC 90.36
- 52 Week Low
- SNOA $1.75
- LRHC $6.40
- 52 Week High
- SNOA $9.00
- LRHC $142.40
- Technical
- Relative Strength Index (RSI)
- SNOA 59.09
- LRHC 40.76
- Support Level
- SNOA $2.97
- LRHC $6.60
- Resistance Level
- SNOA $3.75
- LRHC $7.88
- Average True Range (ATR)
- SNOA 0.27
- LRHC 1.54
- MACD
- SNOA 0.06
- LRHC -0.14
- Stochastic Oscillator
- SNOA 55.83
- LRHC 7.03
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
About LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.